The crystal structure of human ABL2 in complex with GLEEVEC
Salah, E., Ugochukwu, E., Barr, A., Mahajan, P., Shrestha, B., Savitsky, P., Knapp, S.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Tyrosine-protein kinase ABL2 | 292 | Homo sapiens | Mutation(s): 0  Gene Names: ABL2 EC: 2.7.10.2 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P42684 (Homo sapiens) Explore P42684  Go to UniProtKB:  P42684 | |||||
PHAROS:  P42684 GTEx:  ENSG00000143322  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P42684 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
STI Query on STI | B [auth A], C [auth A] | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE C29 H31 N7 O KTUFNOKKBVMGRW-UHFFFAOYSA-N |
Binding Affinity Annotations  | |||
---|---|---|---|
ID | Source | Binding Affinity | |
STI | BindingDB:  3GVU | Ki: min: 13, max: 7000 (nM) from 5 assay(s) | |
Kd: min: 1, max: 1.00e+4 (nM) from 34 assay(s) | |||
IC50: min: 1.1, max: 1.00e+4 (nM) from 66 assay(s) | |||
EC50: min: 34, max: 1000 (nM) from 4 assay(s) | |||
PDBBind:  3GVU | Kd: 10 (nM) from 1 assay(s) |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 88.46 | α = 90 |
b = 99.44 | β = 90 |
c = 87.81 | γ = 90 |
Software Name | Purpose |
---|---|
MAR345 | data collection |
PHASER | phasing |
REFMAC | refinement |
MOSFLM | data reduction |
SCALA | data scaling |